The company behind Marlboro acquired a 45 percent stake in the Canadian cannabis company Cronos Group earlier this year.
Prominent multistate operators lobbying at the federal level are mainly interested in the SAFE Banking Act.
The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states.
The list of companies includes some expected entities, like Chicago-based Cresco Labs and PharmaCann. But there are some surprising companies lobbying, too.
Jurisdictions across California, Nevada, and Oregon are pushing for a national banking solution for cannabis businesses, as well as on other issues.
Archer Daniels Midland is the first big agriculture company to openly lobby on hemp in the US since the crop became legal.
Cannabis Wire has learned that the global company is now lobbying in at least three states.
As cannabis banking gets a hearing in the US Senate, we take a look at the entities that lobbied on the SAFE Banking Act in the second quarter of 2019.
One of the world’s largest cannabis companies is quietly lobbying around cannabis legalization and hemp in the state.
“We’re doing all we can to help the insurance market for cannabis operations mature," said a spokesperson for the Council of Insurance Agents and Brokers.
Cannabis Wire looks at Q1 2019 lobbying disclosure numbers for the major cannabis advocacy and industry groups.
News orgs might want to hold off on quoting the resource, as the “work in progress” contains several inaccuracies.
As legislative priorities shift, what is gained? And what is lost?
Cannabis companies are increasingly lobbying and handing out campaign contributions on both sides of the aisle.
The cannabis debate in Congress is being reshaped along GOP-friendly lines.